Legalizing Marijuana the Strategy for Success
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Medical Cannabis Q&A
Medical Cannabis Q&A 1. What is medical cannabis? The term “medical cannabis” is used to describe products derived from the whole cannabis plant or its extracts containing a variety of active cannabinoids and terpenes, which patients take for medical reasons, after interacting with and obtaining authorization from their health care practitioner. 2. What are the main active ingredients? The chemical ingredients of cannabis are called cannabinoids. The two main therapeutic ones are: THC:CBD a. Tetrahydrocannabinol (THC) is a partial agonist of CB1 and CB2 receptors. It is psychoactive and produces the euphoric effect. Each cannabis product will contain THC and CBD, however b. Cannabidiol (CBD) has a weak affinity for CB1 and CB2 receptors and appears the THC: CBD ratio will differ to exert its activity by enhancing the positive effects of the body’s endogenous depending on the product. cannabinoids. 3. Why do patients take it? Medical cannabis may be used to alleviate symptoms for a variety of conditions. It has most commonly been used in neuropathic pain and other chronic pain conditions. There is limited, but developing clinical evidence surrounding its safety and efficacy, and it does not currently have an approved Health Canada indication. 4. How do patients take it? Cannabis can be smoked, vaporized, taken orally, sublingually, topically or rectally. Different routes of administration will result in different pharmacokinetic and pharmacodynamic properties of the drug. 5. Is it possible to develop dependence on medical cannabis? Yes, abrupt discontinuation after long-term use may result in withdrawal symptoms. Additionally, chronic use may result in psychological dependence. -
Cova How to Open a Cannabis Dispensary US
CONTENTS Introduction .................................................................................................................................. 1 The Basics ..................................................................................................................................... 4 The Licensing & Application Process ........................................................................................ 6 Business Plan Components ...................................................................................................... 8 Cost and Financing .................................................................................................................... 11 Real Estate and Community Involvement ............................................................................... 16 Store Design and Shopping Experience ................................................................................. 19 Building Your Dream Team ....................................................................................................... 22 Sourcing Product and Inventory Management ...................................................................... 26 Point of Sale System and Other Equipment ........................................................................... 29 Security and Safety Plan ........................................................................................................... 32 Conclusion ................................................................................................................................. -
The Highs and Lows of Startups in the Cannabis Industry: a Pestle Analysis of the Current Issues
THE HIGHS AND LOWS OF STARTUPS IN THE CANNABIS INDUSTRY: A PESTLE ANALYSIS OF THE CURRENT ISSUES Jeffrey E. Anderson California State University, Los Angeles Mine Üçok Hughes California State University, Los Angeles Carlin Nguyen California State University, Los Angeles SUMMARY: With recreational cannabis now legal in ten US states, illegal cannabis growing operations are increasingly being replaced with regulated, taxed, and licensed businesses. Sales are predicted to increase roughly 35% from 2017, to more than $8 billion by the end of 2018, and to $22 billion by 2022. Projections like these have contributed to a startup boom in the cannabis industry unseen since the tech boom of the late 1990s. The aim of this paper is to highlight the unique issues faced by startups in the cannabis industry. We examine the elements that influence the cannabis startups by using the PESTLE framework which includes political, economic, social, technological, legal and ecological factors. We identify three types of cannabis startups and provide a brief analysis of differences between them as well as the challenges that they all face. Introduction With recreational use of cannabis currently legalized in ten US states, illegal cannabis growing operations are steadily being supplanted with regulated, taxed, and licensed businesses. Companies operating in these states are now able to legally produce and sell marijuana in their respective states. The 2018 Marijuana Business Factbook predicts sales to increase roughly 35% from 2017, to more than $8 billion by the end of the year (Marijuana Business Daily, 2018). By 2022, sales in the United States are projected to increase by 250%, to $22 billion. -
Marijuana Business Daily
Marijuana Business Daily https://mjbizdaily.com/after-the-safe-vote-in-us-house-heres-what-you-need-to-know-about-the- current-state-of-banking-in-the-marijuana-industry/ After the SAFE vote in US House, here’s what you need to know about the current state of banking in the marijuana industry Published September 27, 2019 The U.S. House of Representatives’ vote approving legislation that would pave the way for financial institutions and insurance companies to serve state-legal marijuana businesses without fear of reprisal is a milestone for the cannabis industry. Nevertheless, the 321-103 House vote is but another step on a long and often bumpy legal road toward changing how marijuana businesses handle their finances. Until we find out whether the SAFE Banking Act will make it to a vote on the Senate floor, here’s what you need to know about the current state of banking in the cannabis industry, as previously reported by Marijuana Business Magazine. How it got started In 2013, while serving as assistant deputy chief at the U.S. Department of Justice, John Vardaman co-wrote the landmark Cole Memo outlining how financial institutions can open and service accounts for marijuana-touching businesses. In effect, the memo gave banks and credit unions the U.S. government’s tacit blessing to serve cannabis businesses, contrary to federal banking laws. Now chief compliance officer and general counsel with Simplifya, a company that helps cannabis businesses manage compliance requirements, Vardaman discussed in an interview how the banking memo came to be, what he would have done differently and his outlook at the time for cannabis banking. -
Should Per Se Limits Be Imposed for Cannabis? Equating Cannabinoid Blood Concentrations with Actual Driver Impairment: Practical Limitations and Concerns
HUMBOLDT JOURNAL OF SOCIAL RELATIONS—ISSUE 35, 2013 Should Per Se Limits Be Imposed For Cannabis? Equating Cannabinoid Blood Concentrations with Actual Driver Impairment: Practical Limitations and Concerns Paul Armentano National Organization for the Reform of Marijuana Laws [email protected] ________________________________________________________________________ Abstract Fourteen US states have amended their longstanding, effect-based DUI drug laws to per se or zero tolerant per se statutes in regard to cannabis. Other states are considering enacting similar legislation. Under these amended traffic safety laws, it is a criminal violation for one to operate a motor vehicle with trace levels of cannabinoids or their metabolites in his or her blood or urine. Opponents of per se cannabinoid limits argue that neither the presence of cannabinoids nor their metabolites are appropriate or consistent predictors of behavioral or psychomotor impairment. They further argue that the imposition of such per se limits may result in the criminal conviction of individuals who may have previously consumed cannabis at some unspecified point in time, but were no longer under its influence. As more states enact statutory changes allowing for the legal use of cannabis under certain circumstances, there is a growing need to re-examine the appropriateness of these proposed per se standards for cannabinoids and their metabolites because the imposition of such limits may, in some instances, inadvertently criminalize behavior that poses no threat to traffic safety, -
Your Business. Our Experience
YOUR BUSINESS. OUR EXPERIENCE. Marijuana The Most Trusted Cannabusiness News Source Since 2011. Business Daily™ REACHING THE ENTIRE CANNABIS INDUSTRY. IT’S OUR SPECIALTY. OUR REACH Founded in early 2011, Marijuana Business Daily has become most trusted news and information resource in cannabusiness. Our publications have the highest readership in the industry. Our events are sell-outs year after year after year. And we’ve been cited everywhere from Harvard Business Review and The Wall Street Journal to Forbes, Fortune and Fast Company. We help cannabis-related companies prosper via our proven information services and exceptional events. OUR PRODUCTS • Marijuana Business Daily™ • Marijuana Business Conference and Expo™ • Marijuana Business Magazine™ • A library of annual business books and publications including the Marijuana Business Factbook™ • Marijuana Industry Directory™ MARIJUANA BUSINESS DAILY NEWSLETTER BANNERS Our daily newsletter has broken hundreds of business, financial and regulatory stories. More than 25,000 business professionals read it. Those subscribers are a captive, target-rich audience for your product. The industry continues to expand faster and faster and our subscriber base follows suit. That’s a lot of eyes on you. DAILY. DIRECTLY. DIGITALLY. THE POWER OF FACE-TO-FACE MARKETING. MARIJUANA BUSINESS CONFERENCE AND EXPO The nation’s oldest and largest cannabis industry event continues to draw record numbers. Our two annual shows allow you to keep up with this industry’s hyper-accelerated rate of change and stay in front of new and existing businesses. SPONSORED EMAIL BROADCASTS Get your brand in front of industry professionals Our focus is quality over quantity with a simple formula: high-caliber attendees, top-notch curated content directly from the name they trust. -
Cannabis in India: Biases and Unrealised Opportunities
CANNABIS IN INDIA: BIASES AND UNREALISED OPPORTUNITIES - Anushree N. Murthy, 3rd Year Student, Symbiosis Law School, Hyderabad - Madhumitha Sridharan, 3rd Year Student, Symbiosis Law School, Hyderabad INTRODUCTION AND HISTORICAL SIGNIFICANCE The consumption of cannabis and its derivatives dates back to several hundred years and has strong roots in Indian culture. It has been said that even the oldest sacred texts of the Vedas reference this ‘psychotropic drug’, which has been passed down generation after generation.1 This drug was obtained from a plant hallucinogen and made into a concoction known as Soma or Amrita: the nectar of immortality. Although the Vedas do not specifically name this beverage, a landmark study from 19712 argues that it was likely to be created from a species of edible mushroom.3 Evidence also suggests that the drug is religiously linked with Shaivite Hindu practices, and the Hindu God Shiva is popularly associated with the drug, often portrayed as smoking marijuana out of a chillum, or a smoking pipe.4The use of cannabis also has its roots in some forms of Buddhism, where certain interpretations of the Fifth Precept suggest that psychoactive plants may be used for medicinal purposes, and in Sikhism, where drinks of Indian hemp were regarded as a “war drink”, where soldiers took a swig of the drink before heading to the battlefield, to relieve anxiety.5 A variant of the drug, bhang, is legally available for consumption in India and is popularly taken as a milk-based beverage. The fat content in the milk is said to increase the absorption of the 1 Michael R. -
Economic and Revenue Impact of Marijuana Legalization in NYS a Fresh Look by James A
Economic and Revenue Impact of Marijuana Legalization in NYS A Fresh Look By James A. Parrott and Michele Mattingly February 2021 About the Authors James A. Parrott is Director of Economic and Fiscal Policies at the Center for New York City Affairs at The New School. Michele Mattingly is a consultant in labor market economics. Copyright © 2021 James A. Parrott and Michele Mattingly 1 Table of Contents Preface .......................................................................................................................................................... 2 Executive Summary ...................................................................................................................................... 2 1. Introduction ...................................................................................................................................... 5 2. Policy choices New York faces in regulating and structuring the legal marijuana market ............ 9 3. New York market demand ............................................................................................................. 13 4. Economic impact of a legal cannabis supply chain ....................................................................... 19 5. New York tax revenue impact from recreational-use marijuana sales ........................................ 24 6. State and local tax impact of the economic activity generated in the cannabis supply chain .... 28 7. Economic and tax effects of market structure and other policy choices .................................... -
Identfication: Industrial Hemp O Marijuana?
Identification: Industrial Hemp branching. Thus, planting density and other production or Marijuana? characteristics do not offer a reliable way to distinguish varieties for law enforcement purposes. Marijuana and industrial hemp are different varieties of the same plant species, Cannabis sativa L. Health Canada announced regulations on March 12, Marijuana typically contains 3 to 15 percent THC on a 1998, that control activities relating to the production, dry-weight basis, while industrial hemp contains less import, export, transport, and sale of industrial hemp than 1 percent (Blade, 1998; Vantreese, 1998). Most (see Appendix I for the fact sheet from Health developed countries that permit hemp cultivation Canada). Production is highly regulated, with farmers require use of varieties with less than 0.3 percent required to obtain annual government permits. Farmers THC. However, the two varieties are indistinguishable cannot have had a drug offense in the past 10 years by appearance. DeMeijer et al. (1992), in a study of 97 and need to have a criminal background check done at Cannabis strains, concluded that short of chemical their own expense. Federal agronomists and police analysis of the THC content, there was no way to dis- will check fields and test plants to make sure that no tinguish between marijuana and hemp varieties. narcotic plants are grown along with the industrial hemp. Industrial hemp can be grown as a fiber and/or seed crop. Grown for fiber, it is planted in dense stands to The European Union (EU) issued rules governing maximize stalk production. Grown for seed or for seed hemp production in 1989, which include registration and fiber, plants are spaced farther apart to encourage of the area to be planted in advance, the use of seed branching and seed production. -
'Ultralight' Weed 20 June 2018
High hopes: French shops use loophole to sell 'ultralight' weed 20 June 2018 Technically, the fragrant marijuana buds on offer at you don't get addicted," an elderly woman said while a new Paris boutique are not meant to be smoked, waiting in line—before the doorman escorted her as the friendly staff and disclaimers remind straight inside. clients—brewing the herb in hot water is advised, as is adding it to food. CBD oil had sold out earlier in the day, so most clients were choosing among three or four different "Smoking is bad for you," a smiling young strains of potent-smelling weed—the popular Swiss salesman tells a customer. Cheese was priced at 30 euros for a 2.3-gram bag ($35 for just under one-tenth of an ounce). But judging by the 45-minute wait to get inside the Cofyshop near the Republique square on a recent 'Smell that!' afternoon, not to mention the smoking paraphernalia behind the counter, that certainly Unlike the coffeeshops in marijuana-friendly seems to be the goal. Amsterdam, no coffee is served and no smoking is allowed at Cofyshop. France is one of Europe's biggest users of cannabis, with an estimated 22 percent of people Fans of its "ultralight" buds as well as cannabis aged 15 to 34 partaking at least once in 2016, resin say they appreciate the calming effects according to the latest data available. without the heavy buzz of traditional marijuana. A recent French poll showed 51 percent in favour "Smell that, it's fantastic!" said a 37-year-old dentist of limited legalisation, reflecting a growing trend at a boutique on the hip Rue Oberkampf in Paris, toward more relaxed rules in Europe and the who said he smokes a joint or two every now and United States. -
Facts on Medical Marijuana (Cannabis) for Dancers
Facts on Medical Marijuana (Cannabis) for Dancers Even with limited information about its effectiveness, the use of marijuana for medical reasons is becoming more widespread around the world. Laws in the US, Canada and Europe have been progressively changing in recent years. With these changes, dancers should have a basic knowledge of what medical marijuana is, the ways it can be taken, and its effects on the human body, mind and function. What is Medical Marijuana? Marijuana comes from the cannabis plant; it contains over 400 chemicals. Medical marijuana uses chemicals from the cannabis plant, or sometimes synthetically made chemicals, to treat diseases or conditions. Medical marijuana is essentially the same product as recreational marijuana but taken for medical purposes. The two main chemicals (cannabinoids) in marijuana known to effect humans are: • Tetrahydrocannabinol (THC) - the major psychoactive compound. This is the chemical that effects changes in the brain of the user, resulting in a “high.” Effects depend on the potency of the THC. THC is fat soluble, meaning that it enters the brain and fat stores of the body quickly • Cannabidiol (CBD) - the major non-psychotropic compound; it is taken for pain without the psychoactive component or “high” Why do you take Medical Marijuana? Cannabinoids affect the human central nervous system and immune system and can lead to altered moods, pain relief, and other temporary changes. Although a great deal more needs to be learned about cannabinoids, and despite mixed research results, plant -
Federal Cannabis Regulations Working Group
FEDERAL CANNABIS REGULATIONS WORKING GROUP: CORE GROUP MEMBERS a working group of experts convened by the Drug Policy Alliance to explore and develop policy recommendations for federal cannabis regulations grounded in public health, equity, and justice reform considerations. QUEEN ADESUYI Queen Adesuyi is a policy manager at the Drug Policy Alliance’s National Affairs office in Washington, D.C., where she works to advance several of DPA’s legislative priorities on the federal level, including marijuana legalization with a racial justice focus, drug decriminalization, and eliminating punitive consequences for drug use and previous convictions. She also advocates for equity/racial justice in plans for the District of Columbia’s emerging marijuana industry, in addition to advancing overdose prevention measures and harm reduction in the District. While at DPA, Queen saw through the introduction of the Marijuana Justice Act, Congress’ first marijuana reform bill that addressed racial justice and justice reform issues. She helped convene and co-leads the Marijuana Justice Coalition. Under her co-leadership, the Marijuana Justice Coalition has worked on the introduction and the historic passage of the Marijuana Opportunity Reinvestment & Expungement (MORE) Act by the U.S. House of Representatives in the 116th Congress. The Coalition continues to work to see the continued improvement of the MORE Act and its successful reintroduction and movement through both chambers of Congress. AAMRA AHMAD Aamra Ahmad is currently the Senior Policy Counsel for the Justice Division of the ACLU and an advocate for federal criminal justice reform. She previously served as legislative counsel to Congressman Bobby Scott (VA-3) and in her previous role at the Federal Public & Community Defenders, oversaw their national litigation strategy that contributed to reduced sentences for over 3,363 people incarcerated under racially unjust drug laws.